Constitutional Isomerization Enables Ultrabright NIR-Ⅱ AIEgen for Brain-Inflammation Imaging

05 July 2019, Version 1
This content is a preprint and has not undergone peer review at the time of posting.


Although biological fluorescence imaging in the second near-infrared window (NIR-Ⅱ, 1000-1700 nm) has embodied the advantages of deep tissue penetration, low background noise and high spatial resolution, shortage of high quantum yield (QY) organic fluorophores has become the bottleneck for further development to this field. Now, an ingenious strategy is proposed to address this: constitutional isomerization by utilizing the molecular design philosophy of aggregation-induced emission (AIE). By solely shifting alkyl chain from meta to ortho position, the resulting twisted structure drives the NIR-Ⅱ fluorophores from aggregation-caused quenching (ACQ) to AIE. In this way, the AIE luminogen (AIEgen), 2TT-oC6B, is provided with an emission peak at 1030 nm and a QY of 11% in nanoparticles, one of the highest reported so far. To endow the targeting ability to deeply located diseases, neutrophils (NEs), the most common immune cells, are used to penetrate the brain tissues. Herein, we show that NEs carrying 2TT-oC6B NPs can penetrate the brain and visualize the deeply located inflammation through intact scalp and skull (3 mm of depth). Notably, the bright 2TT-oC6B fluorophore contributes to a significantly enhanced signal-to-noise ratio of 30.6 in brain inflammation site, which is among the best ones to date. This modern molecule design philosophy could enable a powerful platform for high QY fluorophores and their potential biological applications.


aggregation-induced emission
second near infrared emission
brain inflammation imaging

Supplementary materials

Supporting Information


Comments are not moderated before they are posted, but they can be removed by the site moderators if they are found to be in contravention of our Commenting Policy [opens in a new tab] - please read this policy before you post. Comments should be used for scholarly discussion of the content in question. You can find more information about how to use the commenting feature here [opens in a new tab] .
This site is protected by reCAPTCHA and the Google Privacy Policy [opens in a new tab] and Terms of Service [opens in a new tab] apply.